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A randomized controlled trial of a patient decision-making aid for orthodontics 
 
ABSTRACT 
Introduction: Patient decision-making aids (PDA) are instruments that facilitate shared 
decision-making and enable patients to reach informed, individual decisions regarding 
healthcare. The objective of this study was to assess the efficacy of a PDA compared with 
traditional information provision for adolescent patients considering fixed appliance 
orthodontic treatment.  
Method: Pre-treatment orthodontic patients were randomly allocated into two groups; the 
intervention group received the PDA and standard information regarding fixed appliances, 
and the control group received the standard information only.  Decisional conflict was 
measured using the Decisional Conflict Scale (DCS) and the levels of decisional conflict 
were compared between the two groups.  
Results: Seventy-two patients were recruited and randomized in a ratio of 1:1 to the 
intervention (PDA) and control groups.  Seventy-one patients completed the trial (36 control 
group, 35 intervention group) which satisfied the sample size calculation.  The median total 
DCS score in the PDA group was lower than in the control group (15.63 and 19.53 
respectively) however this difference was not statistically significant (Difference between 
groups 3.90; 95% CI of the difference -4.30 to 12.11).  Gender, ethnicity, age and the time 
point at which patients were recruited did not have a significant effect on DCS scores.  No 
harm was observed or reported for any participant in the study.  
Conclusions: The results of this study showed that the provision of a PDA to adolescent 
patients prior to consenting for fixed appliances did not significantly reduce decisional 
conflict. There may be a benefit in providing a PDA for some individuals, however, it is not 
yet possible to say how these patients could be identified.  
Registration: This trial was registered with the Harrow National Research Ethics Committee 
(Reference 12/LO/0279). 
Protocol: The protocol was not published before trial commencement. 
Funding:  There are no funding or conflicts of interest to be declared.   
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INTRODUCTION 
Patient-centred care, whereby patients are involved in decisions about their own healthcare 
and treatment options, is a core principle of modern healthcare. It is both an ethical and a 
legal obligation which is underpinned by legislation
1
.  Providing patient-centred care 
commonly involves shared decision-making (SDM) where clinicians and patients work 
together to ensure that patients are involved in decisions about their healthcare.   
 
Patient decision-making aids (PDAs) are evidence-based tools that facilitate SDM and are 
used to help patients make personal decisions about their healthcare
2,3
.  They are designed to 
engage patients in the decision-making process, assist them in considering the risks and 
benefits of different treatment options in line with their own values and help them to put 
information into a personal context
3
.  By doing this, PDAs encourage patients to establish 
their preferences and to make decisions that are appropriate for them as individuals
2
.   
 
A large body of evidence exists on the benefits of PDAs and they have been shown to help 
patients make choices in keeping with their own values as well as improving the quality of 
decision-making
4
. PDAs have also been shown to improve patient knowledge, increase 
appreciation of risks, reduce decisional conflict, reduce passive decision-making, reduce the 
number of people who are undecided about their treatment options and improve adherence to 
treatment because patients have taken a more active role in the decision-making process
3,4
. 
Additionally using PDAs commonly results in patients choosing less invasive treatment 
options and their use has often been shown to be more cost effective than when they are not 
used
3,5-7
.  
 
Although PDAs are increasingly used in medicine, they are not commonly used in dentistry
8- 
11
.  This is despite research showing the need to consider patient values and preferences when 
making decisions about dental treatment and there is evidence that dental patients prefer a 
collaborative style of decision-making
12,13
. 
 
Orthodontics often involves decisions where there are several viable treatment options, and 
therefore, lends itself well to SDM and the use of PDAs.  Currently, there are no published 
PDAs for use in orthodontics.  Thus, the use of PDAs in orthodontics is an area which 
requires further research, to assess if the benefits of PDAs which have been shown to exist in 
medicine, also exist in orthodontics. 
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SPECIFIC OBJECTIVES AND HYPOTHESIS 
The aim of this study was to test the efficacy of a PDA in adolescent patients considering 
fixed appliances. This was through the measurement of decisional conflict, using the 
Decisional Conflict Scale (DCS)
14
.  The null hypothesis was that there was no difference in 
the average level of decisional conflict in patients who received the PDA (intervention group) 
compared with those who did not (control group).  
 
MATERIALS AND METHODS 
Trial design and any changes after trial commencement 
This study was a single-centre, prospective, randomized controlled trial with a 1:1 allocation 
ratio. Ethical approval was granted from Harrow National Research Ethics Committee 
(Reference 12/LO/0279).  There were no changes to the trial after its commencement.  
  
Participants, eligibility criteria and settings 
The study was carried out in one National Health Service (NHS) teaching hospital 
orthodontic department. Patients were eligible for inclusion if they were 10 to 16 years old, 
had not undergone any previous orthodontic treatment and did not have any craniofacial 
abnormalities. Patients were recruitment from new patient clinic appointments and from 
appointments to take initial records for treatment planning, both time points were prior to a 
full discussion of treatment options and prior to patients/parents consenting for treatment. 
Information leaflets were given to potential subjects and their parents and consent and assent 
were obtained prior to recruitment to the study.  Patients were recruited between July 2015 
and February 2016.   
 
Interventions 
Participants in both the intervention and control groups received verbal information and 
patient information leaflets, according to their clinician’s normal practice.  To reduce the risk 
of bias due to different information being provided, all patients also received standardised 
verbal information from one of the researchers (KP) regarding the benefits and risks of fixed 
appliances.  Participants in the intervention group additionally received the PDA which the 
researcher discussed in detail with the patient.     
 
The PDA was developed using the International Patient Decision Aids Standards (IPDAS) 
Collaboration criteria
15
.  The material incorporated into the PDA included information from 
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evidence based literature and from in-depth interviews with patients undergoing, or having 
recently completed, fixed appliance treatment. During the interviews patients were asked 
about their understanding of the risks and benefits of fixed appliances and also which risks 
and benefits mattered most to them. This information was then incorporated into the PDA 
alongside that obtained from the literature, which ensured that the PDA included topics which 
were considered important by both patients and clinicians.  The decision aid comprised of 
four A4 pages; the first page gave general information on fixed appliances including what 
they are, what they are used for and what level of commitment is requires from the patient.  
The second page detailed the overall benefits and risks of fixed appliance treatment, the third 
page contained a decision tree to guide patient decision-making and the final page contained 
questions to help patients in the final decision-making process.    
 
All participants then completed the DCS unaided.  This is standard methodology used in the 
majority of PDA research where participants receive all of the information provision and the 
intervention group receive the PDA, and then participants complete a DCS questionnaire only 
after all information has been given
8,9,16,17,
.  The DCS is a validated, multi-dimensional 
questionnaire, which indirectly measures SDM by measuring the degree of uncertainty in a 
patient’s decision-making18.  It is the most popular tool used to measure SDM and the 
efficacy of PDAs
3 
and consists of 16 statements, each with 5 possible responses from 
‘strongly agree’ to ‘strongly disagree’. The DCS is completed by the patient and scored by 
the clinician/researcher to give a total score from 0 (no decisional conflict) to 100 (extremely 
high decisional conflict)
14
.  The questionnaire has good psychometric properties and high 
reliability, with a test-retest correlation of 0.81 and a Cronbach alpha from 0.78 to 0.92
18
.  
Sub-sections of the DCS can also be scored separately to illustrate different elements of 
decisional conflict (uncertainty, informed, values clarity, support, effective decision)
14
.  
 
Outcomes (primary and secondary) and any changes after trial commencement 
The primary outcome measure was the level of decisional conflict, as given by the total DCS 
score, regarding whether or not to proceed with fixed appliances. Demographic information 
and the time point at which patients were recruited (new patient appointment or subsequent 
records appointment) was also recorded so that this information could be used in the 
statistical analysis to assess if any of these factors affected decisional conflict.  There were no 
outcome changes after trial commencement. 
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Sample size calculation 
Using the data from the first 18 participants who completed the study as an internal pilot 
(where the common standard deviation was 11.5), it was calculated that a total of 54 
participants (27 in each group) were required to demonstrate a clinically relevant difference 
between the two groups of nine points on the DCS, with 80% power and a significance level 
of 0.01.  This was increased by 15% due to using the Mann Whitney U test and increased a 
further 15% to allow for any drop-outs or incomplete data.  This gave a total sample size of 
72 participants (36 in each group).   
 
Interim analyses and stopping guidelines 
Not applicable. 
 
Randomisation (random number generation, allocation concealment, implementation) 
A random number sequence was generated using a random number table. Patients were 
randomized in blocks of six to ensure that there were equal numbers of participants in the 
intervention and control groups throughout the study. Allocation concealment was achieved 
using sequentially numbered, sealed, opaque envelopes containing the group to which 
participants were to be allocated.  These envelopes were prepared before the study 
commenced and were only opened once patients were recruited and consented for the study.   
 
Blinding 
Patients were recruited only after they had received the verbal information and patient 
information leaflets from their clinician, thus clinicians did not know if patients had been 
recruited to the study and to which arm of the study they had been allocated.  The verbal 
information given to both the intervention and control groups by the researcher had been 
standardised and practised prior to commencing recruitment to ensure that all patients were 
given the same information. It was not possible to blind the researcher and the participants to 
the group allocation because the researcher worked through the PDA with those allocated to 
this group and patients knew whether or not they had received the PDA.  
 
Statistical analysis 
The total and subscale DCS scores for the control and intervention groups were compared to 
assess the efficacy of the PDA. Since the scores were not normally distributed, the non-
parametric test Mann-Whitney U test was used to compare the two groups.  Univariable 
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linear regression analyses were undertaken to assess if any of the demographic factors or the 
time point at which patients were recruited affected the total DCS scores. The assumptions of 
the regression analysis were verified by a study of the residuals. All statistical analyses were 
completed using SPSS (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, 
Version 22.0. Armonk, NY: IBM Corp). A significance level of 0.01 was used for the Mann 
Whitney U tests instead of the conventional 0.05 to avoid spuriously significant results 
arising from multiple testing. A significance level of 0.10 was used for the univariable 
regression analyses in order to decide which, if any, of the variables to include in a 
multivariable regression analysis as potential confounders when comparing the scores in the 
two groups.   
 
RESULTS 
Participant flow 
Seventy-two patients were randomized in total.  One patient failed to fully complete the DCS, 
therefore data for 71 patients were analysed.  A CONSORT diagram showing the flow of 
participants through the study is shown in Figure 1.   
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Figure 1. CONSORT diagram showing the flow of participants through the study. 
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Baseline data 
The baseline characteristics for age, gender, ethnicity and the time point at which patients 
were recruited were similar in both groups (Table I).  
 
 
Control Group 
(n=36) 
Intervention Group 
(n=35) 
Mean Age [Years (SD)] 
13.1  
(1.7) 
13.0  
(1.8) 
Age Category 
10-13 years 
[n (%)] 
22  
(61.1%) 
21  
(60.0%) 
14-16 years 
[n (%)] 
14  
(38.9%) 
14  
(40.0%) 
Gender 
Male 
[n (%)] 
16  
(44.4%) 
11  
(31.4%) 
Female 
[n (%)] 
20  
(55.6%) 
24  
(68.6%) 
Ethnicity 
White British/Irish 
[n (%)] 
15 
(41.7%) 
21 
(60.0%) 
Other 
[n (%)] 
21  
(58.3%) 
14  
(40.0%) 
Time Point of 
Patient Recruitment 
New Patient 
[n (%)] 
9 
(25%) 
12 
(34.3%) 
Records 
[n (%)] 
27 
(75%) 
23  
(65.7%) 
Table I. Baseline characteristics for patients in each group. 
 
 
Numbers analysed for each outcome, estimation and precision, subgroup analysis 
The median total DCS scores and the median DCS subscale scores were calculated
14
.  For all 
of the DCS subscale scores, the median scores were lower for the intervention group than the 
control group, however, none of these reached statistical significance (Table II).  
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Table II. DCS subscale scores: summary measures and levels of significance. 
 
 
The median total DCS score was lower in the intervention group than in the control group 
(15.63 and 19.53 respectively) although this was not statistically significant (Difference 
between groups 3.90; 95% CI of the difference -4.30 to 12.11) (Table III).  It was also noted 
that there was marked individual variation.  
 
 
DCS Subscale 
Scores 
Control 
Group 
 
Median score 
(Range) 
 
Intervention 
Group 
 
Median score 
(Range) 
 
 
Difference 
between groups 
(95% CIs of 
differences) 
Significance 
(p-value) 
Uncertainty 
25.00 
(0.00 to 50.00) 
16.67 
(0.00 to 58.30) 
8.33 
(-8.08 to 24.74) 
0.36 
Informed 
20.83 
(0.00 to 50.00) 
16.67 
(0.00 to 50.00) 
4.16 
(-4.65 to 12.99) 
0.38 
Values Clarity 
20.83 
(0.00 to 50.00) 
16.67 
(0.00 to 41.70) 
 
4.16 
(-6.77 to 15.11) 
0.47 
Support 
8.33 
(0.00 to 41.70) 
8.33 
(0.00 to 50.00) 
0.00 
(-10.94 to 10.94) 
0.27 
 
Effective Decision 
 
15.63 
(0.00 to 50.00) 
12.50 
(0.00 to 43.80) 
3.13 
(-9.18 to 15.43) 
0.39 
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Total DCS  
Score 
Median Score 
(Range) 
Difference between 
groups 
(95% CI of the 
difference) 
Significance 
(p-value) 
Control 
19.53 
(0.00 to 40.60) 3.90 
(-4.30 to 12.11) 
0.32 
Intervention 
15.63 
(0.00 to 37.50) 
 
Table III. Summary measures and level of significance for the total DCS scores.  
 
Univariable linear regression analyses were undertaken to explore if any of the demographic 
factors or the time point at which patients were recruited affected levels of decisional conflict 
(Table IV).  None of these variables had a statistically significant effect on the total DCS 
scores.   
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Table IV. Univariable linear regression analyses for the total DCS score and the independent 
variables. 
 
 
Harms 
No harm was observed or reported from the participants in the study. 
 
DISCUSSION 
Main findings in the context of existing evidence, interpretation 
This study assessed the efficacy of a PDA for adolescents considering fixed appliances 
compared with traditional information provision through the comparison of decisional 
conflict scores between the intervention and control groups.  The patients in the PDA group 
had a lower median DCS score than those in the control group, however, this did not reach 
statistical significance for the total score (p=0.32) or any of the subscale scores. The 
Independent 
Variable 
Regression 
Coefficient  
95% Confidence 
Interval 
r
2
 
Significance 
(p-value) 
Lower  Upper 
Group 
Control Reference 
-8.24 3.26 0.011 0.39 
PDA -2.49 
 
Age 
 
Years (per year 
increase in age) 
-0.67 -2.37 1.03 0.009 0.43 
Age Category 
10-13 years Reference 
-7.13 4.69 0.002 0.68 
14-16 years -1.22 
Gender 
Female Reference 
-1.30 10.45 0.034 0.12 
Male 4.60 
Ethnicity 
White 
British/Irish 
Reference 
-6.51 5.05 0.001 0.80 
Other -0.73 
Time Point of 
Recruitment 
New Patient 
Clinic 
Reference 
-8.41 4.22 0.006 0.51 
Records Clinic -2.10 
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univariable linear regression analysis showed that patients in the PDA group had, on average, 
a lower total DCS score than those in the control group and confirmed that this did not reach 
statistical significance.  
 
The PDA was clearly beneficial for some patients but not for everybody, therefore it is not 
yet possible to identify which patients will benefit from the PDA.  The majority of research 
into the efficacy of PDAs has been within medicine, where PDAs are commonly found to 
reduce decisional conflict
3
, however, there is little research on the use of PDAs in dentistry, 
and there is limited research with which to compare the results from this study.   
 
A recent study on the efficacy of a PDA for children facing decisions regarding dental 
treatment under sedation or general anaesthesia also found that the decision-making aid 
reduced decisional conflict, but statistical significance was not reached
17
.  The lack of 
statistical significance was attributed to low levels of decisional conflict (control group 
median 20.0, intervention group median 5.0) therefore it was not possible to gain much 
further reduction in scores as a “floor level” had already been reached. The relatively low 
levels of total decisional conflict in the current study (control median 19.53, intervention 
median 15.63 out of 100) may also have precluded large reductions in decisional conflict.   
 
During this study it was observed that a number of patients appeared to have already made a 
definite decision regarding treatment at the point at which they were recruited to the study, 
prior to being given the standardised information.  The decision aid may therefore not have 
had a statistically significant effect because it may not have been given sufficiently early in 
the decision-making process.  It may be that patients were in the decision-making phase prior 
to their hospital appointment and that it would be more appropriate for the PDA to be used by 
the referring practitioner prior to referral.  However, the clinician who goes through the PDA 
with the patient must be adequately qualified to do so, which raises the question as to whether 
referring general dental practitioners have adequate knowledge of orthodontics to undertake 
this and to answer any questions that patients may have.   
 
The univariable linear regression analyses found no significant effects on decisional conflict 
due to age, gender or ethnicity.  However, it must be noted that the age range was relatively 
narrow and only included adolescents.  The majority of published PDAs focus on adults and 
very few PDA studies have analysed if age has an effect on the results
3,19-21
.  Whilst carrying 
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out this study, the researchers observed that older patients appeared more certain about their 
decision regarding treatment and this supports the trend for reduced decisional conflict in 
older patients. It was also observed that younger patients did not appear to engage as well 
with the PDA and it may be that older patients benefit more from a PDA or patients of 
different ages may benefit from the PDA being in different formats.  
 
Although statistical significance was not reached for gender, the largest difference in 
decisional conflict was seen between males and females.  The majority of PDA research does 
not report on gender differences due to a large number of decision aids being gender specific, 
for example those used for decisions concerning breast cancer, prostate cancer, vasectomy, 
and pregnancy decisions, therefore there is little research available with which to compare 
this finding
17,22
. 
 
Although there was a trend for White British/Irish patients to have reduced decisional conflict 
in this study, the results were not statistically significant and the differences may well be due 
to individual variation and personal experiences rather than the ethnicity of the patients 
having a direct effect.   
  
Based on the results of this study, the future use of the PDA must be carefully considered. 
Although some patients experienced reduced decisional conflict, others had increased 
decisional conflict, and it is not yet possible to identify which patients will benefit most. It is 
also important to recognise that increased decisional conflict may not be detrimental if the 
patients are then considering their treatment options more fully, thus making a more informed 
decision. Therefore, whether the PDA reduces or increases decisional conflict, it may still be 
beneficial in helping patients to think about their treatment options more carefully. 
 
Generalisability 
The patients recruited for this study were aged 10 to 16 years old, which represents the age 
range of the majority of orthodontic patients and therefore allows the results to be generalised 
across this age range.  The information given to patients by their clinicians was carried out 
according to each treating clinician’s normal practice.  It is important to recognise that 
clinicians’ standard practices may vary but by randomly allocating patients to the control or 
intervention group, this confounding factor was controlled for. It is also important to 
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acknowledge that, in reality, information provision to patients may vary from clinician to 
clinician and therefore this represents a real world situation.  
Limitations 
This study was conducted in one NHS teaching hospital, therefore, it is not possible to say if 
the same results would be found in different clinical settings and if carried out by different 
clinicians.  
 
Patients were recruited from both new patient clinics and subsequent records appointments 
because no definite treatment decisions had been reached at either of these time points and 
patients were still in the decision-making phase.  There are benefits and limitations to 
recruiting patients from these different clinical settings.  One limitation is that this may 
introduce heterogeneity due to different levels of knowledge and understanding of fixed 
appliances.  However, it was decided to recruit patients from the two different time points so 
that this could be included in the regression analysis to assess if this factor had an effect on 
decisional conflict.  Whilst this is an interesting factor to consider when analysing the results, 
randomising patients to the control or the intervention group ensured that fairly equal 
numbers of patients from each time point were included into each arm of the study.  The 
univariable regression analysis found that the time point from which patients were recruited 
did not have a statistically significant effect on decisional conflict.  Previous studies have 
used a similar methodology, recruiting patients from different clinical settings or time points, 
and none of these studies found the differences in patient recruitment to affect decisional 
conflict which supports the methodology used in our study
18,23,24
. 
 
Whilst this study found a trend for reduced decisional conflict in patients who received the 
PDA compared with those who did not, because patients did not complete a DCS 
questionnaire prior to the information provision, it cannot be said how much their decisional 
conflict changed, it is purely the difference between the two groups which can be commented 
on. Future studies could investigate such changes further. 
 
CONCLUSIONS 
There was no evidence of a difference in the median decisional conflict scores in patients 
who received the PDA compared with those who did not.  Age, gender, ethnicity and the time 
point at which patients were recruited did not have a statistically significant effect on total 
DCS scores. There was noticeable individual variation in the effect of the PDA and, at 
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present, it is not possible to identify those patients who would benefit from the PDA and 
those who would not. Therefore, the routine use of this PDA in adolescent patients 
considering fixed appliances is not recommended in the format used in this study. However, 
shared decision-making is a multi-factorial and dynamic area and there is merit in providing 
patients with tools which help to increase their understanding and knowledge of their 
treatment options and which encourage valid consent and patient-centred care.  
 
INFORMATION REGARDING THE PDA 
For further details about the PDA and requests to use it, please contact the authors. 
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